Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

ClinicalTrials.gov ID: NCT05767034

Public ClinicalTrials.gov record NCT05767034. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Evaluate Efficacy and Safety of Secukinumab Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)

Study identification

NCT ID
NCT05767034
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
381 participants

Conditions and interventions

Interventions

  • Secukinumab 300 mg Drug
  • Secukinumab 150 mg Drug
  • Placebo to secukinumab Other

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 21, 2023
Primary completion
Sep 9, 2025
Completion
Feb 15, 2026
Last update posted
Jun 21, 2026

2023 – 2026

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Arizona Arthritis and Rheumatology Associates PLLC Avondale Arizona 85392
Sun Valley Arthritis Center Ltd Peoria Arizona 85381
AZ Arthritis and Rheumtlgy Rsh PLLC Phoenix Arizona 85032
Precn Comprehensive Clnl Rsch Solns San Leandro California 94578
Providence Saint Johns Health Ctr Santa Monica California 90404
Center for Rheumatology Research West Hills California 91307
Millennium Clinical Trials Westlake Village California 91361
Rheumatology Associates of South Florida Boca Raton Florida 33486
UF Health Cancer Center Gainesville Florida 32610
Sarasota Arthritis Res Ctr Sarasota Florida 34239
West Broward Rheumatology Associates Inc Tamarac Florida 33321
Southeastern Rheumatology Alliance Gainesville Georgia 30501
Klein and Associates Hagerstown Maryland 21740
Massachusetts General Hospital Boston Massachusetts 02114
Clinical Research Inst of MI Saint Clair Shores Michigan 48081
Kansas City Physician Partners Kansas City Missouri 64111
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
Paramount Med Rsrch and Consult LLC Middleburg Heights Ohio 44130
Prolato Clinical Research Center Houston Texas 77054
DM Clinical Research Houston Texas 77070
Accurate Clinical Research Inc Houston Texas 77089
Advanced Rheumatology of Houston Spring Texas 77382

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 110 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05767034, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 21, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05767034 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →